All Access Articles |
- Ionis Pharmaceuticals Phase 3 Study Misses Main Goal | 2026-07-09 | PHARMACEUTICAL
- Key Report for IONS Investors – A Brief Overview | 2026-06-22 | PHARMACEUTICAL
- Ionis Pharmaceuticals' Zilganersen Shows Positive Results in Alexander Disease Study | 2026-04-21 | UNITED STATES
- Ionis Pharmaceuticals Announces Board Changes | 2026-03-09 | UNITED STATES
- Ionis Pharmaceuticals Plans $700M Note Offering | 2025-11-18 | PHARMACEUTICAL
- Analyzing Ionis Pharmaceuticals – A Fundamental Overview | 2025-11-10 | PHARMACEUTICAL
- Ionis Pharmaceuticals Reports 55% Revenue Increase | 2025-10-29 | PHARMACEUTICAL
- FDA Approves Ionis Pharmaceuticals' Dawnzera™ for Hereditary Angioedema | 2025-08-22 | PHARMACEUTICAL
- Ionis Pharmaceuticals' Dawnzera™ Approved by FDA for Hereditary Angioedema | 2025-08-21 | PHARMACEUTICAL
- Investing Insights - Ionis Pharmaceuticals Stock Analysis | 2025-08-14 | PHARMACEUTICAL
- What Ionis Pharmaceuticals Investors Need to Know | 2025-06-18 | PHARMACEUTICAL
- Ionis Pharma's Chief Development Officer to Retire | 2025-06-12 |